Page results
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for children aged 5- 8 patient information leaflet
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
File results
-
FOI/2021/0367 - Religious accommodation
-
FOI/2021/0369 - Telecommunications
-
FOI/2021/0377 - Stonewall diversity applications
-
FOI/2021/0381 - International nursing agency spend
-
FOI/2021/0388 - Digital dictation/ Voice recognition system
-
FOI/2021/0409 - Service Manager for Paediatric Audiology department
-
FOI/2021/0413 - Service providers for patient, transport and private ambulance
-
FOI/2021/0414 - Cyber attacks
-
FOI/2021/0416 - Catering electronic meal ordering system
-
FOI/2021/0417 - A&E attendance for carbon monoxide poisoning